BCRX Financial Facts

Interest expense: -1.24M
Weighted average shares outstanding: -106.45M
See Full Income Statement

Total current liabilities: 15.26M
Non-recourse notes payable: 30M
See Full Balance Sheet

BioCryst Pharmaceuticals, Inc. (BCRX) Earnings

  |   Expand Research on BCRX
Next EPS Date 8/8/14 *Est. EPS Growth Rate -88.9% *Last Qtr.
Average EPS % Beat Rate -19.2% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -2.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/8/14 Q114 -$0.17-$0.17 $0.00N/A$3.34M N/A Details
2/26/14 Q413 -$0.09-$0.08 -$0.01$10.6M$8.81M N/A Details
11/5/13 Q313 -$0.14-$0.14 $0.00$2.4M$2.01M N/A Details
8/8/13 Q213 -$0.23-$0.14 -$0.09$821K$2.01M N/A Details
5/7/13 Q113 -$0.09-$0.15 +$0.06$3.6M$1.31M N/A Details
2/19/13 Q412 -$0.22-$0.16 -$0.06$4.1M$4.02M N/A Details
11/8/12 Q312 -$0.19-$0.21 +$0.02$5.8M$4.63M = Details
8/2/12 Q212 -$0.25-$0.26 +$0.01$4.2M$5.44M = Details